Literature DB >> 24127675

Contemporary management of renal cell carcinoma (RCC) in Victoria: implications for longer term outcomes and costs.

Anthony D Ta1, Damien M Bolton, Margaret K Dimech, Victoria White, Ian D Davis, Michael Coory, Jeremy Millar, Graham Giles.   

Abstract

OBJECTIVE: To describe the contemporary patterns of care for renal cell carcinoma (RCC) using a whole of population series from Victoria. PATIENTS AND METHODS: Retrospective review of medical records of all patients diagnosed and treated for RCC in Victoria in 2009. Patients were identified via the State-wide Victorian Cancer Registry. Patient demographic characteristics, symptoms, stage, and first-line treatment were assessed. Associations between case residential location (metropolitan or rural) and treatment were examined using multivariate logistic regression after adjusting for age, sex, socioeconomic status, treatment in private or public hospital and comorbidity.
RESULTS: Data were obtained for 499 of 577 eligible patients. In all, 413 patients (83%) underwent surgery. Laparoscopic radical nephrectomy (RN) was the most common procedure for Stage I pT1a/pT1b tumours (51.2%); partial nephrectomy (PN) was performed for 27% of Stage I RCC In multivariate analysis, regional patients were less likely to receive PN (odds ratio [OR] 0.39, 95% confidence interval [CI] 0.18-0.85) for Stage I RCC, and less likely to receive systemic therapy for Stage IV RCC (OR 0.06, 95% CI 0.01-0.41). Multidisciplinary team meetings were recorded for only 25% of patients and 3% were enrolled in a clinical trial.
CONCLUSION: Most contemporary patients diagnosed with RCC are still treated with RN, including those with smaller tumours amenable to PN. This may impact future outcomes, including increased risk of chronic kidney disease and its potential financial healthcare burden. Patterns of treatment also appear to differ between metropolitan and regional populations.
© 2013 The Authors. BJU International published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Victoria; cancer registry; chronic kidney disease (CKD); nephrectomy; renal cell carcinoma (RCC)

Mesh:

Year:  2013        PMID: 24127675     DOI: 10.1111/bju.12204

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  7 in total

1.  Eligibility for phase 3 clinical trials of systemic therapy in real-world patients with metastatic renal cell cancer managed in a rural region.

Authors:  Carsten Nieder; Mohsan A Syed; Astrid Dalhaug; Adam Pawinski; Jan Norum
Journal:  Med Oncol       Date:  2017-07-26       Impact factor: 3.064

2.  Variability in surgical management of kidney cancer between urban and rural hospitals in Queensland, Australia: a population-based analysis.

Authors:  Megan K Forbes; Evan P Owens; Simon T Wood; Glenda C Gobe; Robert J Ellis
Journal:  Transl Androl Urol       Date:  2020-06

Review 3.  National nephrectomy registries: Reviewing the need for population-based data.

Authors:  John Pearson; Timothy Williamson; Joseph Ischia; Damien M Bolton; Mark Frydenberg; Nathan Lawrentschuk
Journal:  Korean J Urol       Date:  2015-09-07

4.  Treatment patterns and clinical outcomes in patients with renal cell carcinoma in the UK: insights from the RECCORD registry.

Authors:  J Wagstaff; R Jones; R Hawkins; E Porfiri; L Pickering; A Bahl; J Brown; S Buchan
Journal:  Ann Oncol       Date:  2015-10-21       Impact factor: 32.976

5.  Pazopanib in Metastatic Renal Cancer: A "Real-World" Experience at National Cancer Institute "Fondazione G. Pascale".

Authors:  Sabrina C Cecere; Sabrina Rossetti; Carla Cavaliere; Chiara Della Pepa; Marilena Di Napoli; Anna Crispo; Gelsomina Iovane; Raffaele Piscitelli; Domenico Sorrentino; Gennaro Ciliberto; Piera Maiolino; Paolo Muto; Sisto Perdonà; Massimiliano Berretta; Sandro Pignata; Gaetano Facchini; Carmine D'Aniello
Journal:  Front Pharmacol       Date:  2016-08-31       Impact factor: 5.810

6.  Tumor size and postoperative kidney function following radical nephrectomy.

Authors:  Robert J Ellis; Victoria M White; Damien M Bolton; Michael D Coory; Ian D Davis; Ross S Francis; Graham G Giles; Glenda C Gobe; Rachel E Neale; Simon T Wood; Susan J Jordan
Journal:  Clin Epidemiol       Date:  2019-05-06       Impact factor: 4.790

7.  A Simple Clinical Tool for Stratifying Risk of Clinically Significant CKD after Nephrectomy: Development and Multinational Validation.

Authors:  Robert J Ellis; Sharon J Del Vecchio; Kevin M J Gallagher; Danielle N Aliano; Neil Barber; Damien M Bolton; Etienne T S Chew; Jeff S Coombes; Michael D Coory; Ian D Davis; James F Donaldson; Ross S Francis; Graham G Giles; Glenda C Gobe; Carmel M Hawley; David W Johnson; Alexander Laird; Steve Leung; Manar Malki; David J T Marco; Alan S McNeill; Rachel E Neale; Keng L Ng; Simon Phipps; Grant D Stewart; Victoria M White; Simon T Wood; Susan J Jordan
Journal:  J Am Soc Nephrol       Date:  2020-04-01       Impact factor: 10.121

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.